Kahira Pharmaceuticals & Chemical Industries Company (EGX: CPCI)
Egypt
· Delayed Price · Currency is EGP 116.44
-0.67 (-0.57%)
At close: Dec 19, 2024
EGX: CPCI Revenue
In the fiscal year ending June 30, 2024, Kahira Pharmaceuticals & Chemical Industries Company had annual revenue of 1.36B EGP with 35.38% growth. Kahira Pharmaceuticals & Chemical Industries Company had revenue of 315.74M in the quarter ending June 30, 2024, with 28.64% growth.
Revenue
1.36B
Revenue Growth
+49.38%
P/S Ratio
1.28
Revenue / Employee
722.70K
Employees
1,883
Market Cap
1.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 1.36B | 355.61M | 35.38% |
| Jun 30, 2023 | 1.01B | -106.87M | -9.61% |
| Jun 30, 2022 | 1.11B | 50.07M | 4.71% |
| Jun 30, 2021 | 1.06B | 51.61M | 5.11% |
| Jun 30, 2020 | 1.01B | 47.49M | 4.93% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition